USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Novozymes Biologicals Limited

USPTO PatentsView assignee record - 21 granted patents across 13 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

16.6

Avg claims per patent

-76%

5-year filing velocity

The verdict

Novozymes holds 21 US patents across 13 technology areas, rank #14,166 of 50,000 tracked assignees.

#14,166
of 50,000 US assignees by volume: Top 52%
by Innovation Score (34.7/100): 16.6
avg claims per patent: -76%
filing velocity, last 5 yrs

Portfolio overview

Novozymes Biologicals Limited has been granted 21 US utility patents between 2015 and 2024, placing Novozymes Biologicals Limited at rank #14,166 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.6 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a Foreign Corporation, Novozymes Biologicals Limited is one of the more focused assignees in the PatentsView dataset. By volume, Novozymes sits between Nisshinbo Chemical Inc. (21 patents, rank #14,162) and Neptun Light, Inc. (21 patents, rank #14,170) - the closest US assignees by grant volume. The composite Innovation Score of 34.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 17 in the 2015–2019 window, a -76% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Novozymes Biologicals Limited's 16.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Novozymes Biologicals Limited against peers pursuing similar technology classes.

Nisshinbo Chemical

21
NJOY

21
Nohms

21
Novembal USA

21
NPS Public Furnit…

21
Nubilus B V

21
Namiki Seimitsu H…

21
Neptun Light

21
Novozymes Biologi… ◀

21

What this shows Novozymes holds 21 patents at rank #14,166, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Novozymes

By rank, the assignees closest to #14,166 in granted patent volume.

Leaders in A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR…)

Other assignees with the most granted patents in Novozymes's primary technology class.

Novozymes's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

35 Top 52% higher than 48% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Novozymes Biologicals Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	14.3%
2016	5	23.8%
2017	3	14.3%
2018	4	19.0%
2019	2	9.5%
2020	1	4.8%
2021	2	9.5%
2024	1	4.8%

Which technologies does Novozymes Biologicals Limited patent most?

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 12

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 10

C05F - ORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C, e.g. FERTILISERS FROM WASTE OR REFUSE 10

C12R - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS 9

A01C - PLANTING; SOWING; FERTILISING 7

C05B - PHOSPHATIC FERTILISERS 7

C11D - DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL 6

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 5

D06F - LAUNDERING, DRYING, IRONING, PRESSING OR FOLDING TEXTILE ARTICLES 5

C02F - TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE 4

Y02W - CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT 2

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 1

A01K - ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 1

Top 13 of 13 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#14,166

Across all tracked assignees

Innovation Score

34.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Novozymes Biologicals Limited hold?

Novozymes Biologicals Limited holds 21 US granted patents filed between 2015 and 2024, spanning 13 technology areas.

What is Novozymes Biologicals Limited's Innovation Score?

Novozymes Biologicals Limited has an Innovation Score of 34.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Novozymes Biologicals Limited focus on?

Novozymes Biologicals Limited's top technology area is A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS) with 12 patents. The company has filed patents in 13 CPC subclasses total.

Is Novozymes Biologicals Limited's patent filing rate increasing or decreasing?

Novozymes Biologicals Limited's recent filing velocity is -76% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Novozymes Biologicals Limited's patents?

Novozymes Biologicals Limited's patents average 16.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Novozymes Biologicals Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Novozymes's 21 grants land it in the top 52% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Novozymes ranks #14,166 of 50,000. Top 50 holders
Most of this portfolio concentrates in A01N - see who else leads that technology area. A01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.